AGEN vs AUTL: stock comparison and AI forecast
Agenus Inc (AGEN) and Autolus Therapeutics Plc (AUTL) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
AGEN Agenus Inc
- Market Cap
- $322M
- P/E Ratio
- 65.0x
- Size
- small-cap
- AI Forecast
AUTL Autolus Therapeutics Plc
- Market Cap
- $341M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- AGEN and AUTL have similar market capitalizations ($322M and $341M).
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | AGEN | AUTL |
|---|---|---|
| Market Cap | $322M | $341M |
| P/E Ratio | 65.00x | – |
| P/B Ratio | – | 3.06x |
| EPS | $0.11 | $-1.05 |
| Book Value/Share | – | $0.42 |
| Revenue/Share | $2.98 | $0.38 |
| FCF/Share | $-2.31 | $-0.87 |
Profitability & Margins
| Metric | AGEN | AUTL |
|---|---|---|
| ROIC | 124.6% | – |
| Gross Margin | 99.7% | 1.1% |
| Operating Margin | 38.9% | – |
| EBT Margin | 51.7% | – |
| Tax Rate | – | -0.2% |
Financial Health
| Metric | AGEN | AUTL |
|---|---|---|
| Current Ratio | 0.73x | 4.89x |
| Quick Ratio | – | 4.40x |
| D/E Ratio | – | 2.37x |
| Interest Coverage | 21.2x | 16.4x |
| Working Capital | -$55M | $267M |
Cash Flow
| Metric | AGEN | AUTL |
|---|---|---|
| Operating Cash Flow | -$104M | -$226M |
| Free Cash Flow | -$104M | -$233M |
| Capital Spending | $0.00M | -$7M |
| FCF/Sales | -77.5% | -232.4% |
| CapEx/Sales | 0.0% | 7.1% |
Operational Efficiency
| Metric | AGEN | AUTL |
|---|---|---|
| Asset Turnover | 0.55x | – |
| Receivables Turnover | 7.8x | 2.3x |
| Inventory Turnover | – | 3.0x |
| Fixed Assets Turnover | 9.6x | 1.6x |
| Days Sales Outstanding | 47 days | 162 days |
| Days Inventory | – | 123 days |
| Payables Period | 44854 days | 5 days |
| Cash Conversion Cycle | – | 280 days |
Income Statement
| Metric | AGEN | AUTL |
|---|---|---|
| Total Revenue | $134M | $100M |
| Operating Income | $52M | -$247M |
| R&D Expense | $46M | $113M |
| SG&A Expense | – | $153M |
| Cost of Goods Sold | $380K | $99M |
Dividend & Shareholder Information
| Metric | AGEN | AUTL |
|---|---|---|
| Shares Outstanding | 45M | 266M |
AGEN vs AUTL: stock comparison and AI forecast
Which is bigger, AGEN or AUTL?
AGEN and AUTL have similar market capitalizations ($322M and $341M).
Which one does Intratio's AI model rank higher, AGEN or AUTL?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.